Home›Companies›Biotech & Pharma›Inherent Biosciences

Inherent Biosciences, Inc.

Updated Oct 27, 2026·Latest SEC filing May 31, 2023·Suggest an edit

About Inherent Biosciences

Inherent Biosciences is a private company based in Salt Lake City, Utah, incorporated in 2019 in Delaware. It has reported $1,513,869 raised in one offering on Form D since May 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 19, 2022May 31, 2023$1,513,869target not set12$126KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Inherent Biosciences's Form D filed May 31, 2023.

AO
Andrew Olson
Executive officer

Sources

  1. SECInherent Biosciences, Inc. filing history